Ensign Group (ENSG) Stock May Be Near Fair Value After Growth Stock Spotlight
After roughly doubling over the past five years, Ensign Group no longer looks obviously cheap, and the current share price sits close to its intrinsic value estimate from a Discounted Cash Flow (DCF) model, even though the broader valuation checks lean on the expensive side.
- Ensign Group has delivered a 100.7% total return over five years, which puts extra focus on whether the current valuation leaves enough room for future gains.
- Revenue and earnings growth expectations, supported by the company’s skilled nursing and senior care footprint, may support today’s price, while any slowdown in that growth or pressure on reimbursement and operating costs could weigh on what investors are willing to pay.
- The company scores 1 of 6 on Simply Wall St’s valuation checks. This suggests Ensign Group is not a clear bargain on the broader metrics even if the intrinsic value estimate looks close to fair value today, according to this assessment.
The stock’s next move may depend on whether Ensign Group’s growth can justify paying close to intrinsic value after such a strong five year run.
Find out why Ensign Group's 25.4% return over the last year is lagging behind its peers.
Where Does Ensign Group Sit on Cash Flow?
The Discounted Cash Flow (DCF) approach estimates what Ensign Group’s future cash generation could be worth in today’s dollars. For Ensign Group, the model starts from latest twelve month free cash flow of about $410.5 million and assumes cash flows that grow over time rather than shrink, resulting in a 2 Stage Free Cash Flow to Equity valuation.
On those assumptions, the DCF points to an intrinsic value of about $170 per share, which sits very close to the current share price, implying the stock is roughly 1.0% overvalued on this method. Because the Ensign Group article you read in recent news highlights strong recent revenue and earnings trends, that strength helps explain why the market is comfortable pricing the shares right on top of this cash flow based estimate.
Overall, Ensign Group screens as about fairly valued on this DCF view, with the share price already closely reflecting the model’s cash flow assumptions.
Ensign Group is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.
Where Does Ensign Group Sit on Earnings?
The P/E ratio is a useful way to gauge what investors are paying for each dollar of Ensign Group’s earnings. On this measure, Ensign Group trades at about 27.3x earnings.
That sits a little above both the broader healthcare industry average of around 25.5x and a peer group average of about 16.2x, which indicates investors already attach a premium to the stock. A fair P/E for Ensign Group, based on its growth profile, margins, size and risks, is estimated at roughly 25.3x. The current P/E is therefore only modestly higher than this tailored benchmark rather than wildly out of line.
Overall, Ensign Group appears to be priced roughly fairly on its P/E multiple, with the stock carrying only a small premium to what the earnings model suggests is reasonable.
See what the numbers say about this price — find out in our valuation breakdown.
The Ensign Group Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Ensign Group pick up where the valuation puzzle leaves off by spelling out which expectations for Ensign Group's future growth, margins and earnings would need to hold for the stock to be worth meaningfully more or less than it is today, and they sit on the company’s Community page. Rather than relying on a single multiple or model result, each narrative lays out the assumptions behind its fair value so you can compare them with actual outcomes over time.
If you have a number driven view on whether Ensign Group's skilled nursing and senior care footprint can turn its recent revenue and earnings momentum into stronger long term results, share a Narrative and put your case on record in the Simply Wall St community. It is a chance to add your voice, set out the key drivers you think matter most, and see how your thesis holds up as new data comes through.
Do you think there's more to the story for Ensign Group? Head over to our Community to see what others are saying!
The Bottom Line
Ensign Group now looks roughly fully priced, with the Discounted Cash Flow (DCF) intrinsic value estimate and the current P/E multiple both pointing to an about_right valuation rather than a clear discount. Broader valuation checks are weak, so the stock does not screen as a classic value opportunity despite that fair intrinsic value reading. From here, the key question is whether Ensign Group can sustain the revenue, earnings and cash flow profile implied in those models. This is particularly relevant in the face of reimbursement and cost pressures that could challenge what investors are prepared to pay.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com